arrow_backNeural Digest
AI model analysing human DNA sequences and cell biology
Research

AlphaGenome 2: AI Decodes How Cells Read DNA

DeepMind Blog
auto_awesomeAI Summary

“DeepMind has released AlphaGenome 2, a model designed to predict how DNA sequences and genetic variations influence gene activity across specific human cell types. By decoding the regulatory logic of the genome, the system aims to accelerate understanding of how mutations contribute to disease. This represents a significant step in applying AI to functional genomics, moving beyond protein structure prediction toward the broader challenge of gene regulation.”

Key Takeaways

  • AlphaGenome 2 is DeepMind's AI model that predicts how DNA sequences influence gene expression in specific human cell types.
  • The model targets genetic variations and their downstream effects, with direct applications to understanding the molecular basis of disease.
  • This builds on DeepMind's genomics research lineage, extending AI-driven biological insight beyond protein folding into gene regulation.

DeepMind's AlphaGenome 2 predicts how DNA variations affect specific human cell types and disease.

Part of the 11 November 2026 AI news digest

trending_upWhy It Matters

AlphaGenome 2 addresses one of biology's hardest problems: understanding how the same DNA sequence produces hundreds of different cell types with distinct behaviours. If the model can reliably predict how variants affect cell-type-specific gene regulation, it could dramatically shorten the path from genetic discovery to therapeutic target. Pharmaceutical and genomics companies stand to benefit most immediately, as variant interpretation is a major bottleneck in drug development and rare disease diagnosis. Researchers and practitioners should watch how well AlphaGenome 2 generalises to understudied cell types and rare variants, which will determine its real-world clinical utility.

FAQ

How is AlphaGenome 2 different from AlphaFold?

AlphaFold predicts the 3D structure of proteins from amino acid sequences, while AlphaGenome 2 focuses on gene regulation — predicting how DNA sequences and variants control which genes are switched on or off in specific cell types. They address complementary but distinct biological problems.

What diseases could AlphaGenome 2 help researchers understand?

By predicting how genetic variants affect cell-type-specific gene expression, AlphaGenome 2 could help illuminate the mechanisms behind complex diseases such as cancer, heart disease, and neurological disorders, where non-coding DNA variants play a significant but poorly understood role.

Is AlphaGenome 2 available for researchers to use?

DeepMind has a track record of releasing tools like AlphaFold publicly to accelerate scientific research, though specific access details for AlphaGenome 2 have not been confirmed in this announcement. Researchers interested in access should monitor DeepMind's official channels for release information.

This summary was AI-generated. Neural Digest is not liable for the accuracy of source content. Read the original →
Read full article on DeepMind Blogopen_in_new
Share this story

Related Articles